WOODSTOCK, UK, June 15, 2022 (GLOBE NEWSWIRE) — Owen Mumford, a global leader in the design, manufacture and development of medical devices, today announced the appointment of Bal Johal as Chief research and development, from 4e July 2022.
Johal brings extensive experience in the pharmaceutical and medical device industry, spanning a range of therapeutic areas and dosage forms, most recently working as Vice President of Product Development, Quality, Regulatory and Medical at Circassia. Previously, she held research and development positions at GlaxoSmithKline, Pfizer and Mundipharma Research Ltd.
Research and development has always been at the heart of Owen Mumford’s unique offering and is a major pillar in the strategic direction and development of the business. Johal’s appointment to this central position will improve the quality and strength of the company’s existing pipeline. It also guarantees a well-defined path to achieve new ambitions in innovation, sustainable product design, life cycle analysis and increased positive impact on the experience of healthcare professionals and patients.
“We welcome Bal very warmly to our business,” said Jarl Severn, Managing Director of Owen Mumford. “She has the background, experience and drive to continue accelerating the innovation and forward-thinking that will allow us to achieve ambitious growth and set ourselves apart from the competition.”
Commenting on his appointment, Johal said: “Joining Owen Mumford at this time is very exciting. With a combination of progress already made and very talented people within the organization, I can see that we will be able to deliver a high level of success and innovation that will have a truly positive impact.
About Owen Mumford
Owen Mumford is a leader in the design, manufacture and advancement of medical technology, marketing medical products under its own brand and customized device solutions for the world’s leading pharmaceutical and diagnostic companies. It has pioneered the evolution of medical devices for nearly 70 years with solutions for the ease and comfort of administering lifesaving drugs, safe and comfortable blood sampling and testing, and professional test kits. and rapid self-diagnosis. The company has a global presence in the UK, US, Europe and Asia and is a trusted partner to many of the world’s largest diagnostic and pharmaceutical companies.
For more information visit www.owenmumford.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/84e0a5ca-9966-4d2c-997b-450052a12493